Schedule 13G ownership disclosure
NeuroPace Inc
Common Stock, par value $0.001 per share · CUSIP: 641288105
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- OrbiMed Advisors LLC
Shares: 2,614,184.00 · Class: 8%
- OrbiMed Capital GP VI LLC
Shares: 2,614,184.00 · Class: 8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000780
- Form type
- SCHEDULE 13G/A
- Filer
- NeuroPace Inc
- CIK
- CIK 1528287
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership